FStar Therapeutics Inc (FSTX) Financials

$7.12

$0.00 (0.00%)

As on 17-Mar-2023 09:30EDT

Market cap

$157 Mln

Revenue (TTM)

$21 Mln

P/E Ratio

--

P/B Ratio

2.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	21.18	21.17	11.26	28.32	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	1.13	--	11.26	--	--	--
Operating Expenses	57.93	51.88	33.64	46.67	--	--
Operating Profit (EBIT)	-36.75	-30.71	-22.39	-22.50	--	--
Other Income	-7.51	--	-0.85	--	--	--
Profit before Tax	-45.31	-31.66	-25.62	-23.75	--	--
Provision for Tax	-0.56	-0.37	0.00	-0.74	2.64	0.66
Profit after Tax (Net Income)	-44.75	-31.28	-25.62	-23.01	--	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-44.75	-31.28	-25.62	-23.01	13.27	3.48

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	56.94	96.86	42.99	8.54	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	12.10	14.03	3.64	0.05	--	--
Current Liabilities	14.68	12.14	16.98	29.89	6.14	7.65
Total Liabilities	114.59	123.02	63.61	38.48	--	--

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	34.11	38.28	37.54	19.46	--	--
Current Assets	49.61	84.74	26.07	19.02	6.99	4.52
Total Assets	98.39	123.02	63.61	38.48	--	--
Total Debt*	12.68	13.23	3.16	15.57	--	--
Net Current Assets	34.93	72.60	9.09	-10.87	--	--

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	-27.27	-16.23	-22.11	12.30	13.63
Cash Flow from Investing Activities	--	-0.64	14.05	5.37	-9.62	-9.85
Cash from Financing Activities	--	88.10	15.85	13.26	13.26	0.00
Net Cash Inflow / Outflow	--	--	13.63	--	--	--

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	-2.00	-1.84	-8.54	--	--	--
Cash EPS ($)	--	-1.80	-8.16	--	--	--
Adjusted Book Value ($)	--	5.70	14.33	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.60	-5.41	--	--	--
Free Cash Flow per Share ($)	--	-1.64	-5.65	--	--	--

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	-40.04	-72.93	-190.95	--	--
ROE (%)	-61.68	-44.74	-99.43	-269.60	--	--
ROA (%)	-40.31	-33.52	-50.19	-59.81	--	--
EBIT Margin (%)	-209.16	-145.56	-227.61	-83.86	--	--
Net Margin (%)	-327.55	-147.79	-246.17	-81.26	--	--
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	213.80	0.88	-0.60	--	--	--
EBIT Growth (%)	1.22	-20.26	-7.87	-251.22	286.31	--
Net Profit Growth (%)	0.24	-22.11	-11.32	--	--	--
EPS Growth (%)	62.89	0.78	--	--	--	--
Book Value Growth (%)	-39.66	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	--	-2.73	-1.16	--	--	--
Price / Book Value	2.13	0.88	0.69	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.27	-0.66	-0.58	--	--	--
Close Price ($)	5.12	5.02	9.87	6.32	41.56	53.76
High Price ($)	7.59	15.50	11.16	47.60	63.80	75.72
Low Price ($)	2.07	4.47	3.20	4.68	32.56	25.23
Market Cap ($ Cr)	156.51	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	0.15	0.14	0.07	1.82	--	--
Short term debt to equity ratio	0.04	0.01	0.01	1.82	--	--
Current Ratio	3.38	6.98	1.54	0.64	1.14	0.59
Quick Ratio	3.38	--	--	--	--	--
Interest Coverage	-43.38	-36.51	--	--	--	--

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	38.47	10.92	35.59	40.16	--	--
Asset Turnover	0.19	0.23	0.22	0.74	--	--
Receivable days	--	54.50	249.54	75.13	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.